Prot# X05211: A Phase II Trial of Combination Bortezomib and Rituximab as Front-Line Therapy for Low-Grade Non-Hodgkin's Lymphoma (NU Prot# NU 06H1)

Project: Research project

Project Details

StatusFinished
Effective start/end date6/29/061/31/20

Funding

  • Millennium Pharmaceuticals, Inc (X05211)